^
    Back
    Association details:
    Biomarker:CD20 negative
    Cancer:Diffuse Large B Cell Lymphoma
    Regimen:GDP (cisplatin + dexamethasone injection + gemcitabine)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    University of Oxford
    Title:

    Case report of primary CD20 negative diffuse large B-cell lymphoma

    Published date:
    11/25/2021
    Excerpt:
    A 33-year-old male...diagnosis of primary CD20 negative DLBCL...Post 4 cycles of GDP he achieved partial response...
    DOI:
    https://doi.org/10.1093/omcr/omab114